Posts

Showing posts from July, 2018

Science Validates Undetectable = Untransmittable HIV Prevention Message

Image
People living with HIV whose virus is completely, durably suppressed by treatment will not sexually transmit the virus to an HIV-negative partner, according to NIAID Director Anthony S Fauci, M.D. The success of this HIV prevention strategy is contingent on achieving and maintaining an undetectable viral load—the amount of HIV genetic material in the blood—by taking medication to treat HIV daily as directed. Dr. Fauci delivered these remarks at the July 22  U=U 2018: Celebrate, Activate and Implement! meeting held prior to the 22nd International AIDS Conference (AIDS 2018) in Amsterdam. Over the past two years, a grassroots movement has emerged to promote the value of HIV treatment as prevention through the “ Undetectable = Untransmittable ” campaign, also known as U=U. In his keynote lecture titled “U=U: Science and Policy,” Dr. Fauci traced the science behind the U=U message from early observational studies to more recent, large clinical trials. For nearly two decades, s

Trial of ‘kick and kill’ approach to HIV cure leaves puzzles to be solved

Image
Researchers have reported the results of the first randomized clinical trial to test a novel strategy. The approach involves waking up and then killing the ‘sleeping’ HIV that is hiding in the body using an experimental approach known as ‘kick and kill’. Led by  Imperial College London , the  University of Oxford ,  MRC Clinical Trials Unit at UCL , and the  University of Cambridge , the RIVER study aimed to improve on current care by eradicating HIV from the body, which would represent a major step forward in the search for a cure. The RIVER study, which ran from 2015 to 2018 in London and Brighton, tested the ‘kick and kill’ approach in 60 men recently diagnosed with HIV and who had the virus under control by taking ART. Although investigators found no difference in effect between those participants who received the active ‘kick and kill’ therapy and those who had standard treatment, they say the trial paves the way for testing different combinations of therapies to tac

Combe announces launch of Preventeza Emergency Contraceptive and campaign

As current technologies are advancing more in finding out solutions for health problems, they are marching forward with little steps starting from prevention to cure.One such kind of prevention for unplanned pregnancies and to avoid certain complicated pregnancies Vagisil have announced  a newer method for prevention weeks before.  Combe Inc., the makers of Vagisil ® ,announced the launch of its Preventeza Emergency Contraceptive (levonorgestrel tablet, 1.5 mg)  to showcase solidarity around women's reproductive rights. To demonstrate its commitment to helping women learn more about emergency contraception (EC), the Company is planning to give away up to $1 million worth of free product via the launch of its "Buy One Get One or Give One (BoGoGo)" product campaign where women who purchase Preventeza on Vagisil.com will have the option to get a second one for free to either keep on hand or to give to another woman in their life. New Preventeza by Vagisil, availabl

Nelson Mandela Contribution towards AIDS

Image
In his last years, progressively delicate however he was, Nelson Mandela wound up one of the world's most critical and powerful campaigners against HIV/Aids. It was a troublesome issue to go up against in light of the fact that it pitched him into restriction with his own particular government. Trusting that open encounter would be unhelpful, he picked his words precisely; they were no less intense for that.  By 2000, South Africa was the most exceedingly terrible influenced nation on the planet, with a HIV pervasiveness rate among 15-to 49-year-old of 24.5%: in excess of 4 million individuals, and rising quick.  Things had got to this pass on Mandela's watch. As right on time as 1992, in any case, he had given a discourse despising the social conditions that prompted the simple spread of Aids, from neediness and congestion to the low status of ladies and a transient work framework that implied men were far from home for quite a long time and frequented sex spec

Welcome message from STD&HIV/AIDS 2018

Image
                       “2 nd International Conference on Sexually Transmitted Diseases, Infections and AIDS” Science and Technology when goes hand in hand brings miracle and greater ideology to problems that are still looking for a solution. Here is STD&HIV/AIDS 2018 conference which comes up with the theme " Today's Science Tomorrows Technology in treating Sexually Transmitted Diseases ". This event is organized to bring like minded people who research and studies about Sexually Transmitted Disease and Infectious Disease.Discussing under various aspects of this field will definitely give a solution to treat and cure these diseases. So we welcome you to join hands with us and explore human science and technology. To know more visit: STD&HIV/AIDS 2018 Write back if you have any queries:  stdaids@pulsusevents.org